March 9, 2025 - 13:15

Readers hoping to buy C&F Financial Corporation for its dividend will need to make their move shortly, as the company approaches its upcoming ex-dividend date. Investors are keenly watching this stock, particularly those interested in income-generating investments. The timing of the ex-dividend date is crucial, as only those who purchase shares before this date will be eligible to receive the next dividend payment.
C&F Financial Corporation has established itself as a reliable player in the financial sector, and its dividend history reflects a commitment to returning value to shareholders. As the dividend yield remains attractive, potential investors are encouraged to conduct thorough research and consider their options before making a decision.
With market conditions fluctuating, the opportunity to invest in a company with a solid dividend track record may not last long. Investors should act quickly if they wish to take advantage of this potential income stream.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...